Stability of oral liquid dosage forms in pediatric cardiology: a prerequisite for patient's safety—a narrative review

CM Jîtcă, G Jîtcă, BE Ősz, A Pușcaș, S Imre - Pharmaceutics, 2023 - mdpi.com
The development of safe and effective pediatric formulations is essential, especially in
therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing …

[PDF][PDF] HPLC-UV method approach for the analysis and impurity profiling of captopril

AG Carje, A Balint, V Ion, AL Pop… - Stud. Univ. Babes …, 2019 - academia.edu
The aim of the study was to propose an improved HPLC/UV method for captopril impurity
profiling based on forced degradation studies. Material and methods: the HPLC-UV …

[PDF][PDF] Development of Extemporaneously Prepared Captopril Oral Dosage Forms-A Comprehensive Chronological Study

AM Al-Qaaneh, EA Al-Suhaimi, AA Rabaan… - 2009 - researchgate.net
Captopril is an Angiotensin-converting enzyme inhibitor, its effectiveness as an
antihypertensive agent and in the treatment of several cardiovascular conditions in neonates …